Related Experiment Video
Updated: May 3, 2026

Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Greater weight loss with the omega loop bypass compared to the Roux-en-Y gastric bypass: a comparative study
E Disse1, A Pasquer, P Espalieu
1Department of Endocrinology, Diabetology and Nutrition, Specialized and Integrated Center for Obesity Management, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495, Pierre Bénite, France.
The omega loop bypass (OLB) shows greater weight loss than Roux-en-Y gastric bypass (RYGBP) in short-term studies. Metabolic control is similar, but long-term data is needed for definitive conclusions on these bariatric surgery options.
Area of Science:
- Bariatric surgery
- Surgical innovation
- Obesity treatment
Background:
- Omega loop bypass (OLB) offers better feasibility than Roux-en-Y gastric bypass (RYGBP).
- OLB remains controversial despite similar initial weight loss and metabolic control.
- Short-term outcomes of OLB versus RYGBP require comparative analysis.
Purpose of the Study:
- To compare laparoscopic OLB and RYGBP.
- Evaluate short-term weight loss, metabolic control, and safety.
- Assess the efficacy of a novel bariatric procedure.
Main Methods:
- Matched cohort study comparing 20 OLB and 61 RYGBP patients.
- Prospective data collection on weight loss, metabolic outcomes, and complications.
- Patients matched for age, gender, and initial BMI.
Main Results:
- OLB procedure time was significantly shorter (105 vs. 152 min).
- Greater excess BMI loss percent (EBL%) at 6 months and 1 year for OLB (76.3% vs. 60.0% and 89.0% vs. 71.0%).
- Similar diabetes improvement and comparable complication rates between groups; anastomotic ulcers noted in specific OLB patient subgroups.
Conclusions:
- OLB demonstrates superior short-term weight loss compared to RYGBP.
- Metabolic control efficiency is similar between the two bariatric procedures.
- Long-term follow-up is essential to validate these findings.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Gastric Emptying
Drug Dosing: Obese Patients

